Skip to main content

Macular Degeneration, Early-Onset

OMIM ID:

autosomal dominant

Macular Degeneration, Early-Onset

Alternate Names

EOMD

Defective Genes

FBN2

Clinical Characteristics

Ocular Features

Onset of distorted vision has been reported as early as the fourth decade of life with clinical evidence of pigmentary changes in the macula noted in the fifth decade.  Large areas of central RPE atrophy can be seen.  In the single family reported (a father and his 4 sons), there is considerable clinical heterogeneity in the RPE changes in the fundus.  Acuity is variable depending upon the stage of disease.

Systemic Features

No systemic disease has been reported.

Genetics

Inheritance

Heterozygous mutations in the FBN2 gene, encoding Fibrillin 2, a component protein of the extracellular matrix that segregates with this presumably autosomal dominant macular disease have been reported. 

Pedigree

Autosomal dominant

Autosomal dominant disorders require only one mutation for the disease to be expressed.  Since an affected parent has two chromosomes, only one of which has the mutant gene, parents can expect that half (50%) of their children will receive that one and inherit the disease.  It is common for individuals that inherit the mutation, however, to not have evidence of the disease (nonpenetrance).

Image
Sample pedigree of autosomal dominant inheritance

Autosomal dominant inheritance leads to a vertical pattern of transmission

Treatment & Management

No treatment beyond anti-VEGF therapy is available.  Low vision devices may be helpful.

Selected Resources

Web Resources

Publications

Displaying 1 - 1 of 1

Rare and common variants in extracellular matrix gene Fibrillin 2 (FBN2) are associated with macular degeneration

PubMedID: 24899048